Psoriasis and smoking: links and risks
- PMID: 29387595
- PMCID: PMC5683129
- DOI: 10.2147/PTT.S85189
Psoriasis and smoking: links and risks
Abstract
Smoking is a complex environmental exposure influenced by genetic, environmental, and social factors. Nicotine is the principal alkaloid in tobacco that mediates the addicting effects of tobacco products. Tobacco is a mixture of more than 7,000 chemicals, and smoking is recognized as a risk factor for many diseases in humans, including cardiovascular and pulmonary disease and several cancers, and is the single most preventable cause of mortality worldwide. A number of inflammatory immune-related conditions have been associated with smoking, including psoriasis. Smoking affects the onset of psoriasis. In a pooled analysis of 25 case-control studies, the odds ratio of psoriasis among smokers was 1.78 (95% confidence interval [CI]: 1.53-2.06). A dose-effect relationship is also documented. In a pooled analysis of three cohort studies, the risk of incident psoriasis was 1.81 (95% CI: 1.38-2.36) in those who smoked 1-14 cigarettes per day, and 2.29 (95% CI: 1.74-3.01) in those who smoked ≥25 cigarettes per day. Smoking also impacts on the clinical severity of psoriasis, its response to treatment, and explains some of the associated comorbidities, eg, cardiovascular disease, inflammatory bowel disease, and several cancers (especially those of the respiratory tract). Data on the role of smoking in psoriatic arthritis are less consistent compared with those concerning psoriasis. Several pathophysiological mechanisms may explain the association of psoriasis with smoking, including oxidative stress, interaction with signaling pathways active in psoriasis, and vascular influences. In conclusion, psoriasis is just one of the many diseases associated with smoking, but it is visible and disabling. Dermatologists could play a major role in reducing the health burden of smoking by influencing the patients to change their behavior.
Keywords: comorbidities; nicotine dependence; onset; prognosis; psoriasis; risk; smoking.
Conflict of interest statement
Disclosure The Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED), which the author leads, has received unrestricted research grant from pharmaceutical and cosmetics companies (Ketoprofen Consortium, Menarini, Abbvie, and L’Oreal). The author has served as a consultant or has been a part of advisory boards for Abbvie, Pfizer, Amgen, Novartis, Menarini, Boehringer Ingelheim, and Sanofi. The author reports no other conflicts of interest in this work.
Figures
Similar articles
-
The relationship between smoking, psoriasis and psoriatic arthritis.Expert Rev Clin Immunol. 2019 Jan;15(1):41-48. doi: 10.1080/1744666X.2019.1543591. Epub 2018 Nov 6. Expert Rev Clin Immunol. 2019. PMID: 30380949 Review.
-
Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study.J Am Acad Dermatol. 2019 Mar;80(3):727-734. doi: 10.1016/j.jaad.2018.11.015. Epub 2018 Dec 7. J Am Acad Dermatol. 2019. PMID: 30528570
-
[Impact of cigarette packages warning labels in relation to tobacco-smoking dependence and motivation to quit].Epidemiol Prev. 2012 Mar-Apr;36(2):100-7. Epidemiol Prev. 2012. PMID: 22706360 Italian.
-
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.
-
The changing cigarette, 1950-1995.J Toxicol Environ Health. 1997 Mar;50(4):307-64. doi: 10.1080/009841097160393. J Toxicol Environ Health. 1997. PMID: 9120872 Review.
Cited by
-
The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study.JMIR Res Protoc. 2022 Feb 23;11(2):e26405. doi: 10.2196/26405. JMIR Res Protoc. 2022. PMID: 35195533 Free PMC article.
-
Unconventional Therapy with IgY in a Psoriatic Mouse Model Targeting Gut Microbiome.J Pers Med. 2021 Aug 26;11(9):841. doi: 10.3390/jpm11090841. J Pers Med. 2021. PMID: 34575618 Free PMC article.
-
A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review.Postepy Dermatol Alergol. 2023 Oct;40(5):599-605. doi: 10.5114/ada.2023.129308. Epub 2023 Jul 5. Postepy Dermatol Alergol. 2023. PMID: 38028418 Free PMC article. Review.
-
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women's Health Initiative.Am J Clin Dermatol. 2023 Mar;24(2):325-332. doi: 10.1007/s40257-022-00750-8. Epub 2023 Jan 20. Am J Clin Dermatol. 2023. PMID: 36662365 Free PMC article.
-
Skin Cancer Correlations in Psoriatic Patients.Cancers (Basel). 2023 Apr 25;15(9):2451. doi: 10.3390/cancers15092451. Cancers (Basel). 2023. PMID: 37173917 Free PMC article. Review.
References
-
- US Department of Health and Human Services . How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
-
- Brandt AM. The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product That Defined America. New York, NY: Basic Books; 2007.
-
- Morris PB, Ference BA, Jahangir E, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American College of Cardiology. J Am Coll Cardiol. 2015;66(12):1378–1391. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources